These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 34938106)
1. Hypoxia-Related Gene-Based Signature Can Evaluate the Tumor Immune Microenvironment and Predict the Prognosis of Colon Adenocarcinoma Patients. He X; Ding J; Cheng X; Xiong M Int J Gen Med; 2021; 14():9853-9862. PubMed ID: 34938106 [TBL] [Abstract][Full Text] [Related]
2. Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3. Kong C; Zheng L; Fang S; Chen M; Lin G; Qiu R; Zhao Z; Chen W; Song J; Yang Y; Ji J Technol Cancer Res Treat; 2023; 22():15330338231195494. PubMed ID: 37650153 [No Abstract] [Full Text] [Related]
3. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
4. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms. Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423 [TBL] [Abstract][Full Text] [Related]
5. Identification of the Pyroptosis-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma. Luo B; Lin J; Cai W; Wang M Front Genet; 2021; 12():771847. PubMed ID: 34938319 [TBL] [Abstract][Full Text] [Related]
6. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma. Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K Front Oncol; 2022; 12():904464. PubMed ID: 35912258 [TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Immune-Related Prognostic Genes in the Tumor Microenvironment of Colon Adenocarcinoma. Pan S; Tang T; Wu Y; Zhang L; Song Z; Yu S Front Genet; 2021; 12():778153. PubMed ID: 35047006 [TBL] [Abstract][Full Text] [Related]
8. Copper metabolism patterns and tumor microenvironment characterization in colon adenocarcinoma. Lin J; Luo B; Yu X; Yang Z; Wang M; Cai W Front Oncol; 2022; 12():959273. PubMed ID: 36203457 [TBL] [Abstract][Full Text] [Related]
9. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Jin L; Li C; Liu T; Wang L Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293 [TBL] [Abstract][Full Text] [Related]
10. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma. Lin J; Cao Z; Yu D; Cai W Front Genet; 2021; 12():709133. PubMed ID: 34603375 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma. Liu X; Fang X; Lu L; Liu G Front Genet; 2022; 13():996625. PubMed ID: 36568396 [No Abstract] [Full Text] [Related]
12. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma. Jia X; Zhang T; Lv X; Du H; Sun Y; Guan Y Cancer Biomark; 2023; 38(4):523-535. PubMed ID: 38143338 [TBL] [Abstract][Full Text] [Related]
13. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration. Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W Front Immunol; 2022; 13():959967. PubMed ID: 36177002 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma. Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216 [TBL] [Abstract][Full Text] [Related]
15. Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients. Zhang C; Zhao Z; Liu H; Yao S; Zhao D Front Genet; 2021; 12():657658. PubMed ID: 34322151 [TBL] [Abstract][Full Text] [Related]
16. A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy. Zhou H; Wang Y; Zhang Z; Xiong L; Liu Z; Wen Y Front Genet; 2022; 13():975404. PubMed ID: 36699444 [No Abstract] [Full Text] [Related]
17. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma. Miao YD; Kou ZY; Wang JT; Mi DH World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046 [TBL] [Abstract][Full Text] [Related]
18. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma. Gao H; Xing F BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131 [TBL] [Abstract][Full Text] [Related]
19. Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database. Zhang Z; Li Q; Li A; Wang F; Li Z; Meng Y; Zhang Q Transl Androl Urol; 2021 Dec; 10(12):4353-4364. PubMed ID: 35070817 [TBL] [Abstract][Full Text] [Related]
20. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma. Xiang J; Gong W; Liu J; Zhang H; Li M; Wang R; Lv Y; Sun P Front Genet; 2023; 14():1098190. PubMed ID: 37274780 [No Abstract] [Full Text] [Related] [Next] [New Search]